AUTHOR=Katznelson Ethan , Jerosch-Herold Michael , Cuddy Sarah A. M. , Clerc Olivier F. , Benz Dominik C. , Taylor Alexandra , Rao Shivani , Kijewski Marie Foley , Liao Ronglih , Landau Heather , Yee Andrew J. , Ruberg Frederick L. , Di Carli Marcelo F. , Falk Rodney H. , Kwong Raymond Y. , Dorbala Sharmila 

TITLE=Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=11

YEAR=2024

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1371810

DOI=10.3389/fcvm.2024.1371810

ISSN=2297-055X

ABSTRACT=<sec><title>Background</title><p>Cardiac systolic dysfunction is a poor prognostic marker in light-chain (AL) cardiomyopathy, a primary interstitial disorder; however, its pathogenesis is poorly understood.</p></sec><sec><title>Purpose</title><p>This study aims to analyze the effects of extracellular volume (ECV) expansion, a surrogate marker of amyloid burden on myocardial blood flow (MBF), myocardial work efficiency (MWE), and left ventricular (LV) systolic dysfunction in AL amyloidosis.</p></sec><sec><title>Methods</title><p>Subjects with biopsy-proven AL amyloidosis were prospectively enrolled (April 2016–June 2021; <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">Clinicaltrials.gov</ext-link> ID NCT02641145) and underwent cardiac magnetic resonance imaging (MRI) to quantify rest MBF by perfusion imaging, LV ejection fraction (LVEF) by cine MRI, and ECV by pre- and post-contrast T1 mapping. The MWE was estimated as external cardiac work from the stroke volume and mean arterial pressure normalized to the LV myocardial mass.</p></sec><sec><title>Results</title><p>Rest MBF in 92 subjects (62 ± 8 years, 52 men) with AL amyloidosis averaged 0.87 ± 0.21 ml/min/g and correlated with MWE (<italic>r</italic> = 0.42; <italic>p</italic> &lt; 0.001). Rest MBF was similarly low in subjects with sustained hematologic remission after successful AL amyloidosis therapy (<italic>n</italic> = 21), as in those with recently diagnosed AL amyloidosis. Both MBF and MWE decreased by ECV tertile (<italic>p</italic> &lt; 0.01 for linear trends). The association of ECV with MWE comprised a direct effect (84% of the total effect; <italic>p</italic> &lt; 0.001) on MWE from adverse interstitial remodeling assessed by ECV and an indirect effect (16% of the total effect; <italic>p</italic> &lt; 0.001) mediated by MBF. There was a significant base-to-apex gradient of rest MBF in subjects with higher amyloid burden.</p></sec><sec><title>Conclusions</title><p>In AL amyloidosis, both MBF and MWE decrease as cardiac amyloid burden and ECV expansion increase. Both structural and vascular changes from ECV expansion and myocardial amyloid burden appear to contribute to lower MWE.</p></sec>